DiscERN: An Automated Genome Mining Tool for the Discovery of Evolutionarily Related Natural Products
Owen, J. G.; Woolly, E. F.; Lai, H.-E.; Woolner, V. H.; Little, R. F.
Show abstract
Targeted genome mining to expand known families of natural products is a powerful strategy for discovering bioactive compounds, yet it remains a significant bioinformatics challenge. While tools exist for de novo biosynthetic gene cluster identification and large-scale unsupervised clustering, dedicated methods for the targeted, hypothesis-driven expansion of user-defined BGC families are lacking. Here, we present DiscERN (Discoverer of Evolutionarily Related Natural products), a userfriendly tool designed to address this gap. DiscERN leverages a multi-modal ensemble method that integrates four complementary algorithms classifying biosynthetic gene clusters based on Pfam content, sequence homology, and predicted product structure. This approach allows users to strategically balance discovery sensitivity with predictive precision to suit diverse research goals. We demonstrate DiscERNs utility by applying it to a large collection of actinomycete genomes and validating its predictive power through the successful isolation of discomycin A, a new calcium-dependent lipopeptide antibiotic, from a silent biosynthetic gene cluster. DiscERN provides a robust and accessible platform that streamlines the path from genomic data to a prioritised list of candidate biosynthetic gene clusters, effectively bridging the gap between in silico prediction and bioactive compound discovery.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A novel transformer-based platform for the prediction and design of biosynthetic gene clusters for (un)natural products 94%
- iPRESTO: automated discovery of biosynthetic sub-clusters linked to specific natural product substructures 94%
- Engineering indel and substitution variants of diverse and ancient enzymes using Graphical Representation of Ancestral Sequence Predictions (GRASP) 93%
Similar papers in this journal
- Predicting antimicrobial class specificity of small molecules using machine learning 95%
- Compound activity prediction with dose-dependent transcriptomic profiles and deep learning 93%
- BOLD-GPCRs: A Transformer-Powered App for Predicting Ligand Bioactivity and Mutational Effects Across Class A GPCRs 92%
Similar papers in this journal
Similar papers in this journal
- Metabolomic investigation of the pseudouridimycin producer, a prolific streptomycete 93%
- QMAP: A Benchmark for Standardized Evaluation of Antimicrobial Peptide MIC and Hemolytic Activity Regression 93%
- Tales of 1,008 Small Molecules: Phenomic Profiling through Live-cell Imaging in a Panel of Reporter Cell Lines 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.